Radar Healthcare acquires Cemplicity to expand patient experience capabilities

By Published On: August 12, 2026Last Updated: August 26, 2026
Radar Healthcare acquires Cemplicity to expand patient experience capabilities

Radar Healthcare has acquired Cemplicity, expanding its patient experience and patient-reported outcomes capabilities.

The acquisition brings together two healthcare technology businesses focused on safer care, better experiences, better outcomes and measurable improvement.

Radar Healthcare supports health and care organisations with quality, risk, compliance, incident, audit and action management analytics, as well as patient information and digital consent.

Cemplicity adds capabilities in patient-reported experience measures, or PREMs, patient-reported outcome measures, or PROMs, real-time patient feedback, shared decision-making insights, surgical site inspection surveillance, service recovery feedback and post-care outcomes.

The deal follows Radar Healthcare’s recent acquisition of EIDO Healthcare, a provider of digital consent and patient information solutions.

Radar Healthcare said the two acquisitions expand its ability to support healthcare organisations across quality, safety, patient engagement, informed consent and measurable improvement.

The companies said they aim to connect the patient voice, experience and outcomes with governance and improvement workflows to identify risks earlier, intervene sooner, reduce avoidable harm and improve patient outcomes through evidence-based action.

Radar Healthcare is backed by Marlin Equity Partners, which provides expertise and support as the business continues to invest in its platform, people and customer success capabilities.

Edward Bellamy at Radar Healthcare said: “Radar Healthcare and Cemplicity share a clear purpose: helping healthcare organisations improve quality, deliver safer care, enhance patient experiences and achieve better outcomes.

“Cemplicity brings deep expertise in patient experience, patient-reported outcomes and real-time patient insight, which strongly complements Radar Healthcare’s quality, risk, compliance and improvement platform.

“Together, we can help customers connect what patients are experiencing with the workflows needed to act on that insight and drive meaningful improvement.”

Blaik Wilson at Cemplicity said: “Cemplicity has always focused on helping healthcare teams understand experience and outcomes from the patient perspective.

“Joining Radar Healthcare gives us an exciting opportunity to build on that work, extend our impact and support more organisations in using patient-reported insight to improve care.

“We look forward to working with the Radar Healthcare team on this next chapter.”

Customers will continue to receive the same service, support and product access they rely on today.

Over time, Radar Healthcare and Cemplicity will explore opportunities to connect patient experience, patient-reported outcomes, quality, safety, risk and improvement workflows to create additional value for customers.

Financial terms of the transaction were not disclosed.

Hero image for a medical article: purple background with blood cells; title reads 'The Missing Evidence Behind Sickle Cell’s Repeated Drug Set Backs' with a small logo top-left.The missing evidence behind sickle cell’s repeated drug setbacks
Older man in a blue shirt sits with a tablet, as a caregiver gently holds his hand for support.Remepy raises US$36m to advance Parkinson's treatment into Phase III